首页> 美国卫生研究院文献>Springer Open Choice >Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants
【2h】

Designing and evaluation of sodium selenite nanoparticles in vitro to improve selenium absorption in ruminants

机译:亚硒酸钠纳米粒子的体外设计与评价以提高反刍动物对硒的吸收

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sodium selenite is used to prevent selenium deficiency known as nutritional muscular dystrophy or white muscle disease. In ruminants, selenium supplements are transformed partiality in insoluble form by ruminal microorganisms and its process decrease the selenium absorption in digestive gastrointestinal. However, the objective in this research was focused in encapsulated sodium selenite to be release into of a pH less than four, similarity to an intestinal environment. It was encapsulated by nanoprecipitation and emulsion–evaporation methods, within polymeric nanoparticles. The effect of these methods, polymer proportion (Eudragit RL and RS) and solvent (ethanol and acetone) on the physicochemical (drug entrapment, polidispersity index (PDI) and z potential) and morphological characteristics (particle morphology and particle size) were evaluated. Particle size from each nanoparticles, formulation ranged from 36.64 to 213.86 nm. Particle size, z potential and PDI increased (P ≤ 0.01) when nanoprecipitation and ethanol were used. No significant differences (P > 0.05) were observed when different polymeric proportions were used. Selenium entrapment was 26% when emulsion–evaporation method was used and 78% with nanoprecipitation. Nanoparticles produced by nanoprecipitation were spherical and had a great variation in particle size; on the other hand, nanoparticles produced by emulsion–evaporation were spherical as well as amorphous and presented a homogeneous nanopartcicle size distribution. The release of selenium from nanoparticles was higher in acid pH (less than 4), this condition may represent a better availability of the mineral in the small intestine.
机译:亚硒酸钠用于预防硒缺乏症,称为营养性肌肉营养不良或白肌病。在反刍动物中,硒补充剂通过瘤胃微生物以不溶形式转化为部分,其过程降低了消化胃肠中硒的吸收。但是,这项研究的目标集中在封装的亚硒酸钠中,使其释放到pH值小于4的环境中,与肠道环境相似。它通过纳米沉淀和乳液蒸发方法封装在聚合物纳米颗粒中。评估了这些方法,聚合物比例(Eudragit RL和RS)和溶剂(乙醇和丙酮)对物理化学(药物截留,多分散指数(PDI)和z电势)和形态特征(颗粒形态和粒径)的影响。每个纳米颗粒的粒径范围为36.64至213.86 nm。当使用纳米沉淀和乙醇时,粒径,z电位和PDI增加(P≤0.01)。当使用不同的聚合物比例时,没有观察到显着差异(P> 0.05)。使用乳液蒸发法时硒的截留率为26%,而采用纳米沉淀法时硒的截留率为78%。纳米沉淀法制得的纳米颗粒为球形,粒径变化很大。另一方面,通过乳液蒸发产生的纳米颗粒既是球形的又是无定形的,并呈现出均匀的纳米颗粒尺寸分布。在酸性pH值下,硒从纳米颗粒中的释放更高(小于4),这种情况可能表示小肠中矿物质的利用率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号